The Fight for SMA Screening: A Story of Neglect and Awareness
The announcement that Jesy Nelson's twins had been diagnosed with spinal muscular atrophy type 1 (SMA1) sparked a national conversation about the importance of newborn screening for this rare genetic condition. But for many families affected by SMA, the call for action has been falling on deaf ears for years.
The Call for Action
When Nelson, a former member of Little Mix, revealed her twins' diagnosis, the health secretary, Wes Streeting, responded swiftly, acknowledging the need for better access to diagnoses. He vowed to look beyond SMA screening and emphasized the potential of genomic medicine.
However, for Portia Thorman, whose nine-year-old son, Ezra, has SMA1, this response was bittersweet. Thorman has been tirelessly advocating for SMA screening for nearly four years, writing numerous letters to Streeting. She feels that her efforts have been largely ignored, especially by parliamentarians.
The Struggles of SMA Families
Thorman's experience is not unique. Amy Moffatt, whose five-year-old son, Oakley, was diagnosed with SMA1 at just 10 weeks, shares a similar story. Moffatt had to fight to have her son's symptoms taken seriously, but ultimately received life-saving gene therapy. However, the extensive care required, including physiotherapy and disability adaptations, has been a financial burden.
The Power of Celebrity Advocacy
The media spotlight on SMA following Nelson's announcement has been both a blessing and a curse. While it has raised awareness, it also highlights the frustration of families who have been campaigning for years without success. Charlie Mosey, whose four-year-old son, Rupert, has SMA1, expresses this sentiment, noting the irony of a celebrity's influence in bringing the issue to the forefront.
The Global Perspective
It's worth noting that countries like the US, Germany, Japan, and Ukraine have already implemented SMA screening. With approximately 10,000 to 14,000 babies born with SMA annually worldwide, the need for early detection is clear.
Challenging the Narrative
Molly Everitt, a 23-year-old student with SMA type 3, challenges the negative media portrayal of the condition. She emphasizes that SMA doesn't define one's life and that many individuals with SMA have achieved remarkable feats.
The Way Forward
The Department of Health and Social Care acknowledges the efforts of SMA UK and other advocates, promising a large-scale study into newborn screening. While this is a step in the right direction, the question remains: will it be enough to address the long-standing neglect of SMA screening?
